Načítá se...

PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway

Curcumin has the potential to cure dyslipidemia and nonalcoholic fatty liver disease (NAFLD). However, its therapeutic effects are curbed by poor bioavailability. Our previous work has shown that modification of curcumin with polyethylene glycol (PEG) improves blood concentration and tissue distribu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Liu, Yu, Cheng, Fei, Luo, Yuxuan, Zhan, Zhu, Hu, Peng, Ren, Hong, Tang, Huadong, Peng, Mingli
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523402/
https://ncbi.nlm.nih.gov/pubmed/28770225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8234507
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!